Free Newsletter
Study shows UK recall rise
Manufacturing missteps are behind the near quadrupling of drug and medical device recalls in the UK between 2004 and 2008. A study by marketing concern Blueview Group shows that recalls and product alerts climbed to 94 from just 22, with nearly two-thirds attributed to manufacturing defects.
The study finds that 12 percent of pharma recalls stem from labeling and packaging problems, according to an online report, while nine percent are due to compromised sterility.
Another finding: food product recalls have remained more stable during the rapid rise of pharma and non-food consumer product recalls and safety alerts.
- here's the report
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities


SHARE
WITH: